In an interview with Targeted Oncology, Melissa K. Frey, MD, discussed findings from implementing web-based health information collection of family history in patients with gynecologic cancers.
Laparoscopy remains the gold standard for diagnosis and treatment of the disease.
Intravenous immunoglobulin shows promise as a treatment option for pregnant patients with SARS-CoV-2, influenza, and other respiratory viruses.
Fetal ventriculomegaly, a condition marked by the dilation of cerebral ventricles, is a common finding on second-trimester ultrasounds and requires careful evaluation to determine its causes, severity, and potential impact on neurological outcomes.
Experts evaluate 3 clinical scenarios and determine the appropriate course of action.
Experts evaluate 3 clinical scenarios and determine the appropriate course of action.
Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.
Breaking down barriers through patient selection, new devices, and the latest techniques.
Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.
In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.
What every OB/GYN needs to know to manage this complication.
A recent study analyzing patient portal use amidst the COVID-19 pandemic unveils changes in sociodemographic trends and disparities, highlighting shifts in user behavior and access challenges.
The FDA has granted a regular approval to dostarlimab-gxly (Jemperli; GSK) for adult patients with mismatch repair–deficient, recurrent or advanced endometrial cancer that has progressed on or after a prior platinum-containing regimen in any setting and who are not candidates for curative surgery or radiation.
In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.
Combined hormonal contraceptives such as the combined oral contraceptive pill, the patch, and the vaginal ring each have unique considerations for use in patients with obesity.
First-line maintenance treatment with the PARP inhibitor niraparib yielded a clinically meaningful and statistically significant improvement in progression-free survival vs placebo in Chinese patients with platinum-responsive advanced ovarian cancer, regardless of biomarker status, according to data from the phase 3 PRIME trial.
Emerging technology helps ensure best practices while reducing costs of care.
Family history assessment, genetic screening are key to prevention.
Megan Wasson, DO, and Ceylan Colak, MD, highlight how imaging and multidisciplinary care improve endometriosis diagnosis, treatment, and patient outcomes at the 2025 ACOG ACSM.
Risk assessment, lifestyle counseling, adverse effects, and medication management.
A teenager’s day-to-day behavior can vary greatly. Here are some tips for understanding and navigating this challenging time.
Clinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.
Review bladder disorders and management methods you can discuss with your patients.
Today is Physician Family Day, the perfect time to reflect and address any potential burnout symptoms and spend quality time re-engaging with your loved ones.
Risk assessment and management of brain arteriovenous malformations in pregnancy.
New trial results showed statistically significant improvements in overall survival and progression-free survival.
Cancer programs seek to remove barriers to screenings.